Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.
Journal
The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R
Informations de publication
Date de publication:
05 12 2022
05 12 2022
Historique:
received:
10
06
2022
revised:
02
08
2022
accepted:
01
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
ppublish
Résumé
Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough infections on memory responses. Here, we examine the memory antibodies that develop after a third or fourth antigenic exposure by Delta or Omicron BA.1 infection, respectively. A third exposure to antigen by Delta breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a third mRNA vaccine dose. A fourth antigenic exposure with Omicron BA.1 infection increased variant-specific plasma antibody and memory B cell responses. However, the fourth exposure did not increase the overall frequency of memory B cells or their general potency or breadth compared to a third mRNA vaccine dose. In conclusion, a third antigenic exposure by Delta infection elicits strain-specific memory responses and increases in the overall potency and breadth of the memory B cells. In contrast, the effects of a fourth antigenic exposure with Omicron BA.1 are limited to increased strain-specific memory with little effect on the potency or breadth of memory B cell antibodies. The results suggest that the effect of strain-specific boosting on memory B cell compartment may be limited.
Identifiants
pubmed: 36149398
pii: 213497
doi: 10.1084/jem.20221006
pmc: PMC9513381
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
RNA, Messenger
0
Vaccines, Synthetic
0
mRNA Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI165075
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI138938
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI064003
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111825
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI078788
Pays : United States
Informations de copyright
© 2022 Wang et al.
Références
Elife. 2020 Oct 28;9:
pubmed: 33112236
Immunity. 2021 Aug 10;54(8):1853-1868.e7
pubmed: 34331873
Mol Biol Evol. 2018 May 1;35(5):1253-1265
pubmed: 29474671
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Nature. 2022 Feb;602(7898):654-656
pubmed: 35016196
Nature. 2022 Mar 4;:
pubmed: 35246640
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
N Engl J Med. 2022 Feb 10;386(6):599-601
pubmed: 35030645
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Cell. 2022 Apr 28;185(9):1539-1548.e5
pubmed: 35429436
Cell. 2021 Mar 4;184(5):1201-1213.e14
pubmed: 33571429
JCI Insight. 2022 Oct 10;7(19):
pubmed: 36214224
N Engl J Med. 2022 Jul 7;387(1):86-88
pubmed: 35731894
Sci Immunol. 2022 Jul 29;7(73):eabq3511
pubmed: 35549299
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Lancet. 2022 Feb 12;399(10325):625-626
pubmed: 35063123
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Annu Rev Immunol. 2022 Apr 26;40:413-442
pubmed: 35113731
Nature. 2021 Dec;600(7889):517-522
pubmed: 34619745
Science. 2022 Nov 11;378(6620):619-627
pubmed: 36264829
Cell. 2022 Feb 3;185(3):467-484.e15
pubmed: 35081335
Nature. 2022 Aug;608(7923):593-602
pubmed: 35714668
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288661
Sci Immunol. 2022 Sep 16;7(75):eabq2427
pubmed: 35653438
N Engl J Med. 2022 Feb 3;386(5):492-494
pubmed: 34965337
Nature. 2019 Feb;566(7744):398-402
pubmed: 30760926
Cell. 2021 Apr 15;184(8):2201-2211.e7
pubmed: 33743891
Cell. 2022 Jun 9;185(12):2116-2131.e18
pubmed: 35662412
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
Cell. 2021 Aug 5;184(16):4220-4236.e13
pubmed: 34242578
Front Immunol. 2019 Oct 09;10:2365
pubmed: 31649674
Nat Commun. 2022 Nov 11;13(1):6856
pubmed: 36369151
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Lancet. 2022 Jan 29;399(10323):412-413
pubmed: 35065007
Cell Host Microbe. 2022 Jun 8;30(6):880-886.e4
pubmed: 35436444
Open Forum Infect Dis. 2022 May 07;9(7):ofac227
pubmed: 35818364
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
N Engl J Med. 2022 Apr 7;386(14):1314-1326
pubmed: 35196424
Nature. 2021 Jul;595(7867):426-431
pubmed: 34126625
Nature. 2022 Jul;607(7917):128-134
pubmed: 35447027
Cell. 2022 May 26;185(11):1875-1887.e8
pubmed: 35523182